Systematic review broadens the map for Potomac horse fever agent

A new systematic review in Veterinary Research Communications is putting fresh structure around an old equine disease question: where, exactly, is Neorickettsia risticii circulating? By consolidating reports from multiple continents, the paper suggests the footprint of the agent behind Potomac horse fever is broader, and less neatly bounded, than the disease’s name implies. That lands as equine clinicians are already working with a more expansive understanding of equine neorickettsiosis, including recognition that more than one Neorickettsia species can cause clinically similar disease. (sciencedirect.com)

Historically, Potomac horse fever was identified in horses from the Potomac River region, and for years the disease was treated largely as a North American seasonal enterocolitis syndrome. But the ecology has always been more complicated than the name suggests. Neorickettsia organisms are maintained within digenean trematodes, with life cycles involving freshwater snails, aquatic insects, and vertebrate definitive hosts. Horses are thought to become infected after ingesting infected aquatic insects, which helps explain the disease’s association with waterways and with warm-weather insect emergence. (merckvetmanual.com)

That ecological complexity is one reason the distribution story has stayed messy. The Veterinary Microbiology review describes endemic clinical disease in multiple regions of the U.S. and Canada, as well as parts of South America, including Uruguay and Brazil. A 2020 Scientific Reports paper added molecular confirmation of N. risticii DNA in naturally infected horses in Rio de Janeiro, the first such report from Brazil’s Southeast region, and found evidence of geographic clustering among genotypes. At the same time, reference sources caution that older serosurveys may have overcalled exposure because indirect fluorescent antibody testing can produce false positives, making PCR- or culture-confirmed reports more informative for true range mapping. (sciencedirect.com)

Another important development is that N. risticii is no longer the only bacterium in the frame. In 2020, researchers reported the isolation of a novel Neorickettsia species from horses in eastern Ontario with clinical signs of Potomac horse fever but negative PCR results for N. risticii; that organism was characterized as Neorickettsia findlayensis. The AAEP now lists both N. risticii and N. findlayensis as causative agents of PHF, reflecting a diagnostic and epidemiologic shift that matters when clinicians interpret negative tests, regional patterns, and vaccine expectations. (pubmed.ncbi.nlm.nih.gov)

Expert guidance remains grounded in the clinical realities practitioners know well. The AAEP describes PHF as a non-contagious infectious disease affecting horses of all ages and breeds in endemic areas, with cases usually seen in summer and fall. Clinical signs can include high fever, lethargy, diarrhea, colic, laminitis, and abortion. Merck notes that definitive diagnosis should rely on PCR or isolation of the organism from blood or feces, and recommends testing both sample types because shedding and bloodstream detection may not coincide. Merck also emphasizes that treatment response to early oxytetracycline can be rapid, while laminitis remains one of the most serious complications. (aaep.org)

Why it matters: For veterinary professionals, the bigger takeaway isn’t just that the map is wider. It’s that surveillance quality, not just organism biology, shapes what the profession thinks it knows about PHF risk. A broader documented distribution of N. risticii, plus the emergence of N. findlayensis as a recognized cause of disease, argues for more precise case confirmation, more careful interpretation of historic prevalence data, and continued caution when using vaccination status to lower suspicion. Merck notes that field protection from current inactivated vaccines has been marginal, in part because of antigenic and genomic heterogeneity among strains. In practice, that means clinicians may need to think less in terms of “classic Potomac country” and more in terms of exposure ecology, season, compatible signs, and access to molecular diagnostics. (merckvetmanual.com)

The review also has a disease-surveillance angle beyond individual case workups. If the literature is scattered across regions, species, and diagnostic methods, then underrecognition is a real possibility, especially in areas where equine enterocolitis workups are inconsistent or where PHF is still considered rare. The Brazilian molecular report explicitly argued that limited investigation of equine enterocolitis may be one reason available data remain sparse there. That same logic may apply elsewhere: absence of evidence may still reflect absence of testing. (nature.com)

What to watch: Next steps will likely center on molecular epidemiology, including better separation of N. risticii from N. findlayensis, clearer genotype-by-geography patterns, and more region-specific surveillance tied to trematode and aquatic insect ecology rather than older serologic assumptions. (pubmed.ncbi.nlm.nih.gov)